These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15358010)

  • 21. Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary Disease.
    Su VY; Chang YS; Hu YW; Hung MH; Ou SM; Lee FY; Chou KT; Yang KY; Perng DW; Chen TJ; Liu CJ
    Medicine (Baltimore); 2016 Feb; 95(5):e2427. PubMed ID: 26844454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
    Rouleau JL; Roecker EB; Tendera M; Mohacsi P; Krum H; Katus HA; Fowler MB; Coats AJ; Castaigne A; Scherhag A; Holcslaw TL; Packer M;
    J Am Coll Cardiol; 2004 Apr; 43(8):1423-9. PubMed ID: 15093878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.
    Krum H; Mohacsi P; Katus HA; Tendera M; Rouleau JL; Fowler MB; Coats AJ; Roecker EB; Packer M;
    Am Heart J; 2006 Jan; 151(1):55-61. PubMed ID: 16368292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
    Puente-Maestu L; Calle M; Ortega-González A; Fuster A; González C; Márquez-Martín E; Marcos-Rodriguez PJ; Calero C; Rodríguez-Hermosa JL; Malo de Molina R; Aburto M; Sobradillo P; Alcázar B; Tirado-Conde G;
    Respir Med; 2014 May; 108(5):737-44. PubMed ID: 24635914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenergic blockade in the treatment of congestive heart failure.
    Denbow CE
    West Indian Med J; 2000 Jun; 49(2):102-7. PubMed ID: 10948844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
    Mtisi TF; Frishman WH
    Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design.
    Böhler S; Saubadu S; Scheldewaert R; Figulla HR
    Arzneimittelforschung; 1999 Apr; 49(4):311-7. PubMed ID: 10337449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
    Kotlyar E; Keogh AM; Macdonald PS; Arnold RH; McCaffrey DJ; Glanville AR
    J Heart Lung Transplant; 2002 Dec; 21(12):1290-5. PubMed ID: 12490274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial.
    Hawkins NM; MacDonald MR; Petrie MC; Chalmers GW; Carter R; Dunn FG; McMurray JJ
    Eur J Heart Fail; 2009 Jul; 11(7):684-90. PubMed ID: 19460848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic heart failure with bradycardia.
    Stecker EC; Fendrick AM; Knight BP; Aaronson KD
    Am Heart J; 2006 Apr; 151(4):820-8. PubMed ID: 16569541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 33. Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality.
    Mascarenhas J; Azevedo A; Bettencourt P
    Curr Opin Pulm Med; 2010 Mar; 16(2):106-11. PubMed ID: 20042977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neither carvedilol nor bisoprolol in maximally tolerated doses has any specific advantage in lowering chronic heart failure oxidant stress: implications for beta-blocker selection.
    Chin BS; Gibbs CR; Blann AD; Lip GY
    Clin Sci (Lond); 2003 Oct; 105(4):507-12. PubMed ID: 12841846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
    Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
    Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
    Racine N; Blanchet M; Ducharme A; Marquis J; Boucher JM; Juneau M; White M
    J Card Fail; 2003 Aug; 9(4):296-302. PubMed ID: 13680550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary effects of nebivolol.
    Dal Negro R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):329-34. PubMed ID: 19638367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Beta-blocker prescription and chronic obstructive pulmonary disease].
    Ollivier R; Donal E; Delaval P; Daubert JC; Mabo P
    Ann Cardiol Angeiol (Paris); 2007 Nov; 56(5):231-6. PubMed ID: 17854758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
    Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
    Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.